Fabrazyme 35 mg powder for concentrate for solution for infusion

Company
Sanofi Genzyme
Active Ingredient
Strength
  • Agalsidase Beta: 35 mg
Dosage Form
Pdr/Conc/Soln for Infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
SPC section shown.

Loading the document

Sanofi Genzyme

CITYWEST BUSINESS CAMPUS, DUBLIN 24, IRELAND